27329728|t|MiR-4638-5p inhibits castration resistance of prostate cancer through repressing Kidins220 expression and PI3K/AKT pathway activity
27329728|a|MicroRNAs (miRNAs) are short, conserved segments of non-coding RNA which play a significant role in prostate cancer development and progression. To identify miRNAs associated with castration resistance, we performed miRNA microarray analysis comparing castration resistant prostate cancer (CRPC) with androgen dependent prostate cancer (ADPC). We identified common underexpression of miR-4638-5p in CRPC compared to ADPC samples, which were further confirmed by quantitative PCR analysis. The role of miR-4638-5p in prostate cancer androgen-independent growth has been demonstrated both in vitro and in vivo. We also identified Kidins220 as a target gene directly regulated by miR-4638-5p and shRNA -mediated knockdown of Kidins220 phenocopied miR-4638-5p restoration. Subsequently, we revealed that Kidins220 activates PI3K/AKT pathway, which plays a key role in CRPC. Loss of miR- 4638-5p may lead to CRPC through the activity of Kidins220 and PI3K/AKT pathway. Furthermore, we found that miR-4638-5p, through regulating Kidins220 and the downstream activity of VEGF and PI3K/AKT pathway, influences prostate cancer progression via angiogenesis. The identification of miR-4638-5p down-regulation in CRPC and the understanding of the functional role of miR-4638-5p and its downstream genes / pathways have the potential to develop biomarkers for CRPC onset and to identify novel targets for novel forms of treatments of this lethal form of PCa.
27329728	0	11	MiR-4638-5p	T028	C0017337
27329728	21	61	castration resistance of prostate cancer	T191	C3658266
27329728	81	90	Kidins220	T028	C2681631
27329728	91	101	expression	T045	C0017262
27329728	106	122	PI3K/AKT pathway	T169	C2984369
27329728	132	141	MicroRNAs	T114,T123	C1101610
27329728	143	149	miRNAs	T114,T123	C1101610
27329728	162	180	conserved segments	T086	C0009802
27329728	184	198	non-coding RNA	T114	C0887909
27329728	232	247	prostate cancer	T191	C0600139
27329728	264	275	progression	T046	C1947901
27329728	289	295	miRNAs	T114,T123	C1101610
27329728	312	333	castration resistance	T191	C3658266
27329728	348	373	miRNA microarray analysis	T059	C1449575
27329728	384	420	castration resistant prostate cancer	T191	C3658266
27329728	422	426	CRPC	T191	C3658266
27329728	433	467	androgen dependent prostate cancer	T191	C0600139
27329728	469	473	ADPC	T191	C0600139
27329728	497	512	underexpression	T045	C0017262
27329728	516	527	miR-4638-5p	T028	C0017337
27329728	531	535	CRPC	T191	C3658266
27329728	548	552	ADPC	T191	C0600139
27329728	553	560	samples	T077	C2347026
27329728	594	619	quantitative PCR analysis	T059	C2733022
27329728	633	644	miR-4638-5p	T028	C0017337
27329728	648	663	prostate cancer	T191	C0600139
27329728	664	691	androgen-independent growth	T191	C1516170
27329728	719	727	in vitro	T080	C1533691
27329728	732	739	in vivo	T082	C1515655
27329728	760	769	Kidins220	T028	C2681631
27329728	782	786	gene	T028	C0017337
27329728	809	820	miR-4638-5p	T028	C0017337
27329728	825	830	shRNA	T114	C2930586
27329728	841	850	knockdown	T063	C2350567
27329728	854	863	Kidins220	T028	C2681631
27329728	876	887	miR-4638-5p	T028	C0017337
27329728	932	941	Kidins220	T028	C2681631
27329728	952	968	PI3K/AKT pathway	T169	C2984369
27329728	996	1000	CRPC	T191	C3658266
27329728	1010	1022	miR- 4638-5p	T028	C0017337
27329728	1035	1039	CRPC	T191	C3658266
27329728	1064	1073	Kidins220	T028	C2681631
27329728	1078	1094	PI3K/AKT pathway	T169	C2984369
27329728	1123	1134	miR-4638-5p	T028	C0017337
27329728	1155	1164	Kidins220	T028	C2681631
27329728	1173	1183	downstream	T082	C0522506
27329728	1196	1200	VEGF	T116,T123	C0078058
27329728	1205	1221	PI3K/AKT pathway	T169	C2984369
27329728	1234	1261	prostate cancer progression	T191	C1739135
27329728	1266	1278	angiogenesis	T042	C0302600
27329728	1302	1313	miR-4638-5p	T028	C0017337
27329728	1314	1329	down-regulation	T044	C0013081
27329728	1333	1337	CRPC	T191	C3658266
27329728	1386	1397	miR-4638-5p	T028	C0017337
27329728	1406	1416	downstream	T082	C0522506
27329728	1417	1422	genes	T028	C0017337
27329728	1425	1433	pathways	T044	C0037080
27329728	1464	1474	biomarkers	T201	C0005516
27329728	1479	1483	CRPC	T191	C3658266
27329728	1539	1549	treatments	T061	C0087111
27329728	1573	1576	PCa	T191	C0600139